Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001193125-26-203344

EVP, Chief Development Officer acquired 23,464 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Forbes William P · EVP, Chief Development Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2026-04-30 Exercise or conversion : show line 1 in the form +11,694 197,341 D
2026-04-30 Exercise or conversion : show line 2 in the form +11,770 209,111 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-04-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −11,694 128,638 D
2026-04-30 Exercise or conversion : show line 4 in the form Restricted Stock Units −11,770 176,545 D
Loading xslF345X06/ownership.xml…